← Scoopfeeds — Intelligent news, curated.
Revolution Medicines reports phase 3 pancreatic cancer trial results
business

Revolution Medicines reports phase 3 pancreatic cancer trial results

Investing.com · May 31, 2026, 12:13 PM · Also reported by 4 other sources

Revolution Medicines reports phase 3 pancreatic cancer trial results

Read full story on Investing.com → More top stories

Also covered by

STAT News STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug STAT News STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug NPR News Experimental pill promises new hope for deadly pancreatic cancer The Guardian Cancer jab can eradicate entire tumours in patients, trial shows

More in business

Investing.com
Berkshire Hathaway to acquire homebuilder Taylor Morrison for $6.8 bln
Investing.com
South Korea export growth hits four-decade high as chip sales hit record on AI boom
Investing.com
Asia stocks count on AI boom to offset Gulf risks
Bloomberg Markets
India Rate Risks, Fiscal Worries Add to Pressure on Bond Yields
Investing.com
US stock futures rise with focus on Iran peace deal, payrolls
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop